Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCND3 | P30281 | 2/20 | 0.48 |
| ▸ | CDK4 | P11802 | 1/20 | 0.48 |
| ▸ | CCND1 | P24385 | 1/20 | 0.48 |
| ▸ | CCND2 | P30279 | 1/20 | 0.48 |
| ▸ | JAK3 | P52333 | 14/20 | 0.45 |
| ▸ | PTK2 | Q05397 | 14/20 | 0.45 |
| ▸ | JAK2 | O60674 | 14/20 | 0.45 |
| ▸ | IGF1R | P08069 | 1/20 | 0.42 |
| ▸ | CCNK | O75909 | 1/20 | 0.41 |
| ▸ | CCNA2 | P20248 | 1/20 | 0.41 |
| ▸ | CDK2 | P24941 | 1/20 | 0.41 |
| ▸ | CDK9 | P50750 | 1/20 | 0.41 |
| ▸ | CDK6 | Q00534 | 1/20 | 0.41 |
| ▸ | NAMPT | P43490 | 1/20 | 0.41 |
| ▸ | BTK | Q06187 | 1/20 | 0.41 |
| ▸ | BRD4 | O60885 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30878697 | 0.90 | CCND3 (0.56) | CCND3CDK4CCND1CCND2JAK3 | |
| SCHEMBL30878828 | 0.87 | CCND3 (0.56) | CCND3CDK4CCND1CCND2JAK3 | |
| SCHEMBL30879031 | 0.87 | WEE1 (0.48) | CCND3CDK4CCND1CCND2JAK3 | |
| SCHEMBL30878921 | 0.87 | JAK2 (0.46) | CCND3CDK4CCND1CCND2JAK3 | |
| SCHEMBL30879080 | 0.84 | BTK (0.47) | CCND3CDK4CCND1CCND2JAK3 | |
| SCHEMBL30878776 | 0.84 | CCND3 (0.46) | CCND3CDK4CCND1CCND2JAK3 | |
| SCHEMBL30879266 | 0.82 | CCND3 (0.44) | CCND3CDK4CCND1CCND2JAK3 | |
| SCHEMBL30878808 | 0.78 | CCND3 (0.62) | CCND3CDK4CCND1CCND2JAK3 | |
| SCHEMBL30878988 | 0.78 | CCND3 (0.51) | CCND3CDK4CCND1CCND2PTK2 | |
| SCHEMBL30879056 | 0.78 | CDK4 (0.47) | CCND3CDK4CCND1CCND2JAK3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4612148-A1 | 2-AMINO-PYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE AND 7-AMINO-1-PYRIMIDO[4,5-D]PYRIMIDIN-2(1 H)-ONE DERIVATIVES AS EGFR INHIBITORS FOR THE TREATMENT OF CANCER | Cancer Research Technology Limited (GB) | 2025-09-10 | — | — | EP | disclosed |
| WO-2024094963-A1 | 2-AMINO-PYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE AND 7-AMINO-1-PYRIMIDO[4,5-D]PYRIMIDIN-2(1 H)-ONE DERIVATIVES AS EGFR INHIBITORS FOR THE TREATMENT OF CANCER | CANCER RESEARCH TECHNOLOGY LIMITED (GB) | 2024-05-10 | — | — | WO | disclosed |